Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) lipidome and chronic kidney disease: Enrichment in triacylglycerols and diacylglycerols.

Journal of clinical lipidology·2026
Same author

Authors' Response to Comments by Di Tanna et al.

Statistics in medicine·2026
Same author

Lipoprotein(a) lipidome and diet: responses to reducing saturated fat intake in African Americans in a randomized trial.

Journal of lipid research·2026
Same author

Prevalence of undiagnosed hypertension and risk assessment using a validated survey in community-based screening in Amman, Jordan.

PloS one·2026
Same author

Meta-Analysis of Cost-Effectiveness.

Statistics in medicine·2026
Same author

Dietary and Physical Activity Habits of Potential Living Kidney Donors.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2026

Related Experiment Video

Updated: May 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Blinding in clinical trials: a practical approach.

Heejung Bang1, Jongbae J Park

  • 1Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, CA 95616, USA. hbang@ucdavis.edu

Journal of Alternative and Complementary Medicine (New York, N.Y.)
|November 13, 2012
PubMed
Summary

Blinding in clinical trials is crucial for objective results but often overlooked. This article offers practical strategies to improve blinding practices throughout trial stages for more reliable research outcomes.

More Related Videos

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
07:12

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

Published on: April 11, 2025

Measuring the Behavioral Effects of Intraocular Scatter
05:10

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

Related Experiment Videos

Last Updated: May 17, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
07:12

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

Published on: April 11, 2025

Measuring the Behavioral Effects of Intraocular Scatter
05:10

Measuring the Behavioral Effects of Intraocular Scatter

Published on: February 18, 2021

Area of Science:

  • Clinical Trials Methodology
  • Research Integrity
  • Evidence-Based Medicine

Background:

  • Blinding is a critical component of clinical trials, ensuring unbiased results.
  • It often receives less attention than other trial elements like randomization and compliance.
  • Knowledge of intervention assignment can influence participant and researcher behavior.

Purpose of the Study:

  • To highlight the importance of blinding in clinical trials.
  • To provide practical suggestions for improving blinding implementation and assessment.
  • To help researchers confidently manage blinding-related issues.

Main Methods:

  • Review of existing literature on blinding in clinical trials.
  • Discussion of blinding considerations at different stages of a clinical trial (design, conduct, analysis).
  • Proposal of practical and flexible strategies for enhancing blinding practices.

Main Results:

  • Blinding is essential for maintaining objectivity and reducing bias in clinical research.
  • Despite its importance, blinding is not always adequately addressed or successful.
  • Effective blinding requires careful planning and consistent effort throughout the trial.

Conclusions:

  • Improving blinding practices is vital for the credibility of clinical trial findings.
  • Researchers should proactively address blinding challenges at all trial phases.
  • This article offers actionable recommendations to enhance the rigor and practicality of blinding in clinical research.